Paxos Looking for Investors to Close Out the Remaining Seed Round
The momentum continues...
After our Nexus Forum presentation at AUA 2026, we have been receiving a lot of interest in the Paxos Medical story and the opportunity to end the tyranny of the catheter as the lifetime sentence for the 15+ million Americans living with Underactive Bladder.
We just closed $2M of our $6M Seed round.
The remaining $4M funds the path to first-in-human feasibility: cadaver and animal studies, an acute human study for target validation, FDA pre-submission, and chronic study approval.
If you are interested in backing capital-efficient medtech with strong IP, established reimbursement, and an indication that has stalled for too long, we have room for a few more aligned investors to round out the Seed.
Let's talk.
Patients are waiting.
